140 related articles for article (PubMed ID: 32129695)
1. Serum betatrophin levels are significantly increased in obese patients compared to lean patients regardless to the presence of PCOS.
Keyif B; Goksever Celik H; Karamustafaoglu Balci B; Mehves Celebi M; Ozaltin S; Takmaz O; Buyru F; Baştu E
Gynecol Endocrinol; 2020 Aug; 36(8):678-681. PubMed ID: 32129695
[TBL] [Abstract][Full Text] [Related]
2. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
[TBL] [Abstract][Full Text] [Related]
3. Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome.
Erol O; Özel MK; Ellidağ HY; Toptaş T; Derbent AU; Yılmaz N
J Obstet Gynaecol; 2017 Jul; 37(5):633-638. PubMed ID: 28319674
[TBL] [Abstract][Full Text] [Related]
4. Circulating Angiopoietin-like 8 protein (ANGPTL8/Betatrophin) in patients with polycystic ovary syndrome: a systematic review and multi effect size meta-analysis.
Varikasuvu SR; Panga JR; Satyanarayana MV
Gynecol Endocrinol; 2019 Mar; 35(3):190-197. PubMed ID: 30614305
[TBL] [Abstract][Full Text] [Related]
5. Serum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome.
Eksi Haydardedeoglu F; Bagir GS; Haydardedeoglu B; Bozkirli E; Bakiner O; Metin K; Ertorer ME
Gynecol Endocrinol; 2019 Mar; 35(3):224-227. PubMed ID: 30241452
[TBL] [Abstract][Full Text] [Related]
6. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.
Calan M; Yilmaz O; Kume T; Unal Kocabas G; Yesil Senses P; Senses YM; Temur M; Gursoy Calan O
Endocrine; 2016 Jul; 53(1):271-9. PubMed ID: 26832343
[TBL] [Abstract][Full Text] [Related]
7. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile.
Sahin Ersoy G; Altun Ensari T; Vatansever D; Emirdar V; Cevik O
Gynecol Endocrinol; 2017 Feb; 33(2):119-123. PubMed ID: 27690684
[TBL] [Abstract][Full Text] [Related]
8. Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome.
Kahraman S; Altinova AE; Yalcin MM; Gulbahar O; Arslan B; Akturk M; Cakir N; Toruner FB
J Endocrinol Invest; 2018 Sep; 41(9):1069-1074. PubMed ID: 29363048
[TBL] [Abstract][Full Text] [Related]
9. Adipose Insulin Resistance and Circulating Betatrophin Levels in Women with PCOS.
He Y; Hu W; Yang G; Guo H; Liu H; Li L
Biomed Res Int; 2020; 2020():1253164. PubMed ID: 32076603
[TBL] [Abstract][Full Text] [Related]
10. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
11. [Elevated serum levels of betatrophin in patients with polycystic ovary syndrome and the influential factors].
Song S; Wang J; Guo C; Jiang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):969-74. PubMed ID: 27640796
[TBL] [Abstract][Full Text] [Related]
12. Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome.
Remsberg KE; Talbott EO; Zborowski JV; Evans RW; McHugh-Pemu K
Fertil Steril; 2002 Sep; 78(3):479-86. PubMed ID: 12215321
[TBL] [Abstract][Full Text] [Related]
13. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.
Yilmaz MA; Duran C; Basaran M
J Endocrinol Invest; 2016 Jan; 39(1):45-53. PubMed ID: 26100531
[TBL] [Abstract][Full Text] [Related]
14. Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome.
Qu Q; Zhao D; Zhang F; Bao H; Yang Q
J Int Med Res; 2017 Feb; 45(1):193-202. PubMed ID: 28222635
[TBL] [Abstract][Full Text] [Related]
15. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
Bradbury RA; Lee P; Smith HC
Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
[TBL] [Abstract][Full Text] [Related]
16. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
[TBL] [Abstract][Full Text] [Related]
17. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.
Grulet H; Hecart AC; Delemer B; Gross A; Sulmont V; Leutenegger M; Caron J
Clin Endocrinol (Oxf); 1993 Jun; 38(6):621-6. PubMed ID: 8334748
[TBL] [Abstract][Full Text] [Related]
18. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
19. Betatrophin: no relation to glucose metabolism or weight status in obese children before and after lifestyle intervention.
Roth CL; Elfers C; Lass N; Reinehr T
Pediatr Diabetes; 2017 Sep; 18(6):485-491. PubMed ID: 27402552
[TBL] [Abstract][Full Text] [Related]
20. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.
Acién P; Quereda F; Matallín P; Villarroya E; López-Fernández JA; Acién M; Mauri M; Alfayate R
Fertil Steril; 1999 Jul; 72(1):32-40. PubMed ID: 10428145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
